| scholarly article | Q13442814 |
| P50 | author | Dag Aarsland | Q41599688 |
| P2093 | author name string | J P Larsen | |
| J L Cummings | |||
| E Tandberg | |||
| K Karlsen | |||
| C Janvin | |||
| N G Lim | |||
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| Parkinsonism: onset, progression, and mortality | Q28259134 | ||
| Depression and Parkinson's disease: a review | Q35313173 | ||
| Behavioral complications of drug treatment of Parkinson's disease | Q37771070 | ||
| Mental disorders and the use of psychotropic drugs in an 85-year-old urban population. | Q39414971 | ||
| The epidemiology of Parkinson's disease in the county of Rogaland, Norway | Q39417904 | ||
| The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia | Q39605807 | ||
| Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence. | Q40678775 | ||
| Cognitive deficits in Parkinson's disease | Q41328582 | ||
| Anxiety and Parkinson's disease | Q41442784 | ||
| Alzheimer disease and frontotemporal dementias. Behavioral distinctions | Q43496874 | ||
| Apathy is not depression | Q45296345 | ||
| Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders | Q45296643 | ||
| Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study | Q48210742 | ||
| Risk factors for depression in Parkinson disease | Q48719363 | ||
| Reliability, validity, and clinical correlates of apathy in Parkinson's disease | Q48852465 | ||
| Depression and disability in Parkinson's disease. | Q51003628 | ||
| Feelings of anxiety and associated variables in a very elderly population. | Q51095306 | ||
| Psychiatric morbidity in patients with Parkinson's disease. | Q52059154 | ||
| The spectrum of behavioral changes in Alzheimer's disease. | Q53210662 | ||
| Depression in classic versus akinetic-rigid Parkinson's disease | Q64922801 | ||
| Neuropsychiatric aspects of progressive supranuclear palsy | Q71761133 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 492-496 | |
| P577 | publication date | 1999-10-01 | |
| P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
| P1476 | title | Range of neuropsychiatric disturbances in patients with Parkinson's disease | |
| P478 | volume | 67 |
| Q64864842 | Q64864842 |
| Q54166132 | A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. |
| Q36307871 | A matter of motion or an emotional matter? Management of depression in Parkinson's disease |
| Q38218083 | Advances in non-dopaminergic treatments for Parkinson's disease |
| Q37275088 | Alexithymia and apathy in Parkinson's disease: neurocognitive correlates |
| Q37849153 | An approach to and the rationale for the pharmacological management of behavioral and psychological symptoms of dementia |
| Q46852351 | An effect of dopamine depletion on decision-making: the temporal coupling of deliberation and execution |
| Q48407672 | An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease |
| Q50710876 | An interpretative phenomenological analysis of delusions in people with Parkinson's disease. |
| Q30936490 | Analyses of nursing home residents with Parkinson's disease using the minimum data set. |
| Q50648271 | Anhedonia in Japanese patients with Parkinson's disease. |
| Q64291102 | Apathy Associated With Impaired Recognition of Happy Facial Expressions in Huntington's Disease |
| Q47948376 | Apathy and associated factors in Mexican patients with Parkinson's disease |
| Q48930449 | Apathy and depression in Parkinson disease |
| Q36666584 | Apathy and the basal ganglia |
| Q90736949 | Apathy as a behavioural marker of cognitive impairment in Parkinson's disease: a longitudinal analysis |
| Q47382226 | Apathy in Mild Parkinson's Disease: Neuropsychological and Neuroimaging Evidence |
| Q35560120 | Apathy in Parkinson's disease. |
| Q38383130 | Apathy in Parkinson's disease: A systematic review and meta-analysis. |
| Q37718935 | Apathy in Parkinson's disease: an electrophysiological study |
| Q38431646 | Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment |
| Q39665359 | Apathy in Parkinson's disease: diagnostic and etiological dilemmas |
| Q47776320 | Apathy in Parkinson's disease: neurophysiological evidence of impaired incentive processing |
| Q39952638 | Apathy in drug-naïve patients with incident Parkinson's disease: the Norwegian ParkWest study. |
| Q48391747 | Apathy in late-life depression among Taiwanese patients |
| Q34108538 | Apathy in neurologic disorders |
| Q48499238 | Apathy is associated with activities of daily living ability in Parkinson's disease |
| Q48247456 | Apathy may herald cognitive decline and dementia in Parkinson's disease |
| Q38616633 | Apathy: a practical guide for neurologists |
| Q34432509 | Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease |
| Q36414663 | Assessment of GDNF in primate models of Parkinson's disease: comparison with human studies |
| Q37505818 | Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease |
| Q47915648 | Associations of specific psychiatric disorders with isolated focal dystonia, and monogenic and idiopathic Parkinson's disease |
| Q35203991 | Behavioral changes associated with deep brain stimulation surgery for Parkinson's disease. |
| Q35236819 | Behavioral disturbances in Parkinson's disease |
| Q39376178 | Behavioural coping patterns in Parkinson's patients with visual hallucinations |
| Q35467692 | Behavioural disorders, Parkinson's disease and subthalamic stimulation |
| Q42413314 | Behind the mask : a study on the clinical course, psychopathology and impact on quality of life in idiopathic Parkinson's disease |
| Q64102414 | Beyond Emotions: Oscillations of the Amygdala and Their Implications for Electrical Neuromodulation |
| Q50635221 | Carer burden in apathy and impulse control disorders in Parkinson's disease. |
| Q35194993 | Cerebral correlates of psychotic syndromes in neurodegenerative diseases |
| Q27318127 | Characterization of cognitive deficits in rats overexpressing human alpha-synuclein in the ventral tegmental area and medial septum using recombinant adeno-associated viral vectors |
| Q38598375 | Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease |
| Q34457767 | Clinical aspects of palliative care in advanced Parkinson's disease |
| Q34264188 | Clinical overview of the synucleinopathies |
| Q38253089 | Clinical psychology and disability studies: bridging the disciplinary divide on mental health and disability |
| Q48641663 | Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease |
| Q36227376 | Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations |
| Q28299302 | Coaxil (tianeptine) in the treatment of depression in Parkinson's disease |
| Q47923287 | Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias |
| Q48566146 | Cognitive and Neuropsychiatric Features of Early Parkinson's Disease |
| Q36492310 | Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options |
| Q44028610 | Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). |
| Q36700296 | Conceptualization of depression in Parkinson's disease |
| Q38661735 | Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia |
| Q44056635 | Dementia and depression determine care dependency in Parkinson's disease: analysis of 1,449 outpatients receiving nursing care in Germany |
| Q92224078 | Depression Screening from Voice Samples of Patients Affected by Parkinson's Disease |
| Q61932597 | Depression in Parkinson's disease |
| Q47759633 | Depressive Symptoms are Frequent in Atypical Parkinsonian Disorders. |
| Q73733180 | Diagnostic classification of organic psychiatric disorders after aneurysmal subarachnoid hemorrhage: a comparison between ICD-10, DSM-IV and the Lindqvist & Malmgren classification system |
| Q34024723 | Dissociating apathy and depression in Parkinson disease. |
| Q48505475 | Does subthalamic nucleus stimulation induce apathy in Parkinson's disease? |
| Q43984944 | Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients |
| Q35089933 | Dysthymia and apathy: diagnosis and treatment |
| Q54986684 | Early fine motor impairment and behavioral dysfunction in (Thy-1)-h[A30P] alpha-synuclein mice. |
| Q36141974 | Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. |
| Q33146234 | Efficacy and safety of clozapine and olanzapine: an open-label study comparing two groups of Parkinson's disease patients with dopaminergic-induced psychosis |
| Q64944300 | Epidemiology of Parkinson's disease |
| Q50883183 | Evaluation of anxiety in Parkinson's disease with some commonly used rating scales. |
| Q37514014 | Evidence for gender differences in cognition, emotion and quality of life in Parkinson's disease? |
| Q34610660 | Examination of the Lille Apathy Rating Scale in Parkinson disease |
| Q45771985 | Examining carer stress in dementia: the role of subtype diagnosis and neuropsychiatric symptoms. |
| Q33987540 | Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse |
| Q45179274 | Experiences of apathy in people with Parkinson's disease: a qualitative exploration. |
| Q42408193 | Facial emotion recognition impairment in patients with Parkinson's disease and isolated apathy |
| Q91726976 | Factor Analysis of the Apathy Scale in Parkinson's Disease |
| Q38896237 | Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders |
| Q36011226 | Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease |
| Q47764486 | Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease |
| Q37685662 | Hallucinations and psychosis in Parkinson's disease |
| Q37071647 | Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networks |
| Q34610681 | How cautious should we be when assessing apathy with the Unified Parkinson's Disease Rating Scale? |
| Q92027397 | How is cognition in subthalamic nucleus deep brain stimulation Parkinson's disease patients? |
| Q46849830 | Impact of psychiatric disorders on Parkinson's disease : a nationwide follow-up study from Sweden |
| Q37275669 | Impaired planning in Parkinson's disease is reflected by reduced brain activation and connectivity |
| Q37635622 | Impulsive and Compulsive Behaviors in Parkinson's Disease: The Norwegian ParkWest Study. |
| Q35884924 | Inflammatory Pathways in Parkinson's Disease; A BNE Microarray Study |
| Q43923068 | Influence of benzodiazepines on antiparkinsonian drug treatment in levodopa users |
| Q34242604 | Influence of depressive symptoms on dopaminergic treatment of Parkinson's disease |
| Q38752575 | Inhibitory dysfunction contributes to some of the motor and non-motor symptoms of movement disorders and psychiatric disorders |
| Q48700487 | Insomnia and depressive symptoms in patients with Parkinson's disease. Relationship to health-related quality of life. An interview study of patients living at home |
| Q57462116 | Interaction Between Neuropsychiatric Symptoms and Cognitive Performance in Parkinson's Disease: What Do Clinical and Neuroimaging Studies Tell Us? |
| Q35158376 | Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases? |
| Q38024984 | Late-stage Parkinson disease. |
| Q50269272 | Late-stage Parkinson's disease: the Barcelona and Lisbon cohort |
| Q35171214 | Let's inhibit our excitement: the relationships between Stroop, behavioral disinhibition, and the frontal lobes |
| Q48499341 | Major depressive disorder in Parkinson's disease: a register-based study |
| Q36635473 | Management of Parkinson's disease dementia : practical considerations |
| Q36847271 | Management of the behavioral aspects of Parkinson's disease |
| Q51957248 | Measuring change in psychiatric symptoms using the Neuropsychiatric Inventory: Nursing Home version. |
| Q35065682 | Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys. |
| Q34081731 | Modulation of habit formation by levodopa in Parkinson's disease |
| Q48539794 | Mood disturbances and cognitive functioning in Parkinson's disease: the effects of disease duration and side of onset of motor symptoms |
| Q38372996 | Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review |
| Q34001965 | Negative symptoms: the 'pathology' of motivation and goal-directed behaviour |
| Q28069542 | Neural Correlates for Apathy: Frontal-Prefrontal and Parietal Cortical- Subcortical Circuits |
| Q48107484 | Neuroanatomical correlates of apathy in Parkinson's disease: A magnetic resonance imaging study using voxel‐based morphometry |
| Q42483926 | Neurobehavioral Anomalies in the Pitx3/ak Murine Model of Parkinson's Disease and MPTP. |
| Q82029414 | Neurobehavioral disorders in Parkinson's disease |
| Q35615127 | Neurocognitive correlates of apathy and anxiety in Parkinson's disease |
| Q35149177 | Neuropsychiatric co-morbidities in non-demented Parkinson's disease |
| Q34341299 | Neuropsychiatric complications of medical and surgical therapies for Parkinson's disease |
| Q44063087 | Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease |
| Q48421008 | Neuropsychiatric problems in Parkinson's disease: comparisons between self and caregiver report |
| Q35556420 | Neuropsychiatric profiles in dementia. |
| Q43582416 | Neuropsychiatric symptoms in Nigerian patients with Parkinson's disease |
| Q37600783 | Neuropsychiatric symptoms in Parkinson's disease |
| Q36219665 | Neuropsychiatric symptoms in Parkinson's disease with mild cognitive impairment and dementia |
| Q24678238 | Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress |
| Q37714081 | Neuropsychiatric symptoms in untreated Parkinson's disease |
| Q34489109 | Neuropsychiatry of the basal ganglia |
| Q33708283 | Neurotoxic in vivo models of Parkinson's disease recent advances. |
| Q36400926 | Non-motor symptoms of Parkinson's disease: diagnosis and management |
| Q37449905 | Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment |
| Q35654026 | Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy? |
| Q74226585 | Nonrecognition of depression in Parkinson's disease |
| Q30657153 | Organic psychosis: Insight into the biology of psychosis |
| Q28250516 | PARK8 LRRK2 parkinsonism |
| Q28293655 | Parkinson's disease-related disorders in the impulsive-compulsive spectrum |
| Q36778067 | Pleiotropic effects of Drosophila neuralized on complex behaviors and brain structure |
| Q37406585 | Predictors of health status in nondepressed and nondemented individuals with Parkinson's disease |
| Q51891737 | Prevalence, patterns, service needs, and assessment of neuropsychiatric disorders among people with epilepsy in residential care: validation of the Neuropsychiatric Inventory as a caregiver-rated measure of neuropsychiatric functioning in epilepsy. |
| Q89552687 | Progression of Neuropsychiatric Symptoms over Time in an Incident Parkinson's Disease Cohort (ICICLE-PD) |
| Q59131829 | Psychiatric Manifestation in Patients with Parkinson's Disease |
| Q34574771 | Psychiatric aspects of Parkinson's disease |
| Q35838935 | Psychiatric aspects of Parkinson's disease--an update |
| Q38206498 | Psychiatric issues in cognitive impairment |
| Q92266681 | Psychiatric morbidity, cognitive dysfunction and quality of life in drug-naive patients with Parkinson's disease: A comparative study |
| Q34666435 | Psychiatric symptoms in Parkinson's disease |
| Q48846072 | Psychiatric symptoms screening in the early stages of Parkinson's disease |
| Q40238981 | Psychometric properties of the apathy evaluation scale in patients with Parkinson's disease. |
| Q47106246 | Psychosis and concurrent impulse control disorder in Parkinson's disease: A review based on a case report |
| Q39004255 | Psychosis in Parkinson Disease: A Review of Etiology, Phenomenology, and Management. |
| Q34638941 | Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptoms |
| Q47158887 | Psychosocial therapy for Parkinson's-related dementia: intervention development. |
| Q36673715 | Recognition and management of neuropsychiatric complications in Parkinson's disease |
| Q37155476 | Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target? |
| Q48371449 | Reduced neural connectivity but increased task-related activity during working memory in de novo Parkinson patients |
| Q36021869 | Reduced task-related functional connectivity during a set-shifting task in unmedicated early-stage Parkinson's disease patients |
| Q53479482 | Reduction of white matter integrity correlates with apathy in Parkinson's disease. |
| Q37127123 | Reformulating psychological difficulties in people with Parkinson's disease: the potential of a social relational approach to disablism |
| Q80079177 | Relationship between age and subtypes of psychotic symptoms in Parkinson's disease |
| Q64874004 | Remote delivery of psychological interventions for Parkinson's disease |
| Q47758162 | Resting-state frontostriatal functional connectivity in Parkinson's disease-related apathy |
| Q44696944 | Risk of incident depression in patients with Parkinson disease in the UK. |
| Q35803990 | Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa |
| Q51758888 | Subthreshold depression in patients with Parkinson's disease and dementia--clinical and demographic correlates. |
| Q37084012 | Suicidal and death ideation in Parkinson's disease |
| Q91725427 | Systematic review of neuropsychological instruments used in subthalamic nucleus deep brain stimulation in Parkinson´s disease patients |
| Q26999386 | Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System |
| Q35483927 | Taste responses in patients with Parkinson's disease. |
| Q36226345 | The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease |
| Q47638005 | The Neuropsychiatric Inventory--NPI. Validation of the Danish version |
| Q38467172 | The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson's disease dementia |
| Q37796036 | The challenge of non-motor symptoms in Parkinson's disease |
| Q38190119 | The effects of exercise on cognition in Parkinson's disease: a systematic review. |
| Q91810535 | The efficacy of a "cocktail therapy" on Parkinson's disease with dementia |
| Q38763134 | The factor structure of the Brief Symptom Inventory-18 (BSI-18) in Parkinson disease patients |
| Q91174246 | The impact of apathy on cognitive performance in the elderly |
| Q52000825 | The neuropsychological assessment of dementia. |
| Q43649463 | The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire |
| Q33917203 | The relationships between mild cognitive impairment and phenotype in Parkinson's disease |
| Q34019751 | The spectrum of cognitive impairment in Lewy body diseases |
| Q36326055 | Toys and gadgets: construct validity of apathy in Parkinson's disease |
| Q37831398 | Treatment of depressive symptoms in Parkinson's disease |
| Q42649280 | Underutilization of deep brain stimulation for Parkinson's disease? A survey on possible clinical reasons |
| Q36842189 | Update on the use of pramipexole in the treatment of Parkinson's disease |
| Q33767361 | Use of latent variable modeling to delineate psychiatric and cognitive profiles in Parkinson disease |
| Q59544556 | Validation of the Psychosis and Hallucinations Questionnaire in Non-demented Patients with Parkinson's Disease |
| Q34114062 | Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe |
| Q37974179 | Visual hallucinations in the differential diagnosis of parkinsonism |
| Q92546131 | White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease |
| Q47303989 | Why not try harder? Computational approach to motivation deficits in neuro-psychiatric diseases |
| Q53287471 | [Apathy an neurodegenerative diseases: pathophysiology, diagnostic evaluation, and treatment] |
| Q84054821 | [Apathy in Parkinson's disease] |
| Q84116216 | [Deep brain stimulation for Parkinson's disease] |
| Q80027950 | [Hallucinations and dementia. Prevalence, clinical presentation and pathophysiology] |
| Q86524384 | [Parkinson's disease and psychoses] |
Search more.